Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.75 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | ARG2 | P78540 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | TOP1 | P11387 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ANPEP | P15144 | 1/20 | 0.37 |
| ▸ | DHFR | P00374 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.36 |
| ▸ | AGXT | P21549 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10366617 | 1.00 | MAOB (0.75) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL155054 | 0.87 | MAOB (1.00) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL155055 | 0.87 | MAOB (1.00) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL1524697 | 0.87 | MAOB (1.00) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL10367402 | 0.81 | MAOB (0.68) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL10367401 | 0.81 | MAOB (0.68) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL15068413 | 0.77 | MAOB (0.70) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL21558233 | 0.77 | MAOB (0.70) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL7301824 | 0.77 | MAOB (0.55) | MAOBCA1CA2ARG2IDO1 | |
| SCHEMBL628859 | 0.76 | MAOB (0.78) | MAOBCA1CA2ARG2IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090306376-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME | MITSUI CHEMICALS, INC. (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20070054084-A1 | Optical recording medium and compound used for the same | MITSUI CHEMICALS, INC. (JP) | 2007-03-08 | — | — | US | disclosed |
| EP-1672626-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED IN THE OPTICAL RECORDING MEDIUM | Mitsui Chemicals, Inc. (JP) | 2006-06-21 | — | — | EP | disclosed |
| US-20060088786-A1 | Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus | MITSUI CHEMICALS, INC. (JP) | 2006-04-27 | — | — | US | disclosed |
| EP-1484191-A1 | REWRITABLE OPTICAL INFORMATION RECORDING MEDIUM AND RECORDING/REPRODUCING METHOD, RECORDING/REPRODUCING DEVICE | Sony Corporation (JP) | 2004-12-08 | — | — | EP | disclosed |
| US-5399596-A | Cationic polymerization, production of epoxy resins, polystyrene, polyorthoesters, polyorthocarbonates | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1995-03-21 | — | — | US | disclosed |
| EP-0331496-B1 | POLYFLUORIDE SULFONIUM COMPOUNDS AND POLYMERIZATION INITIATOR THEREOF | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1992-09-16 | — | — | EP | disclosed |
| EP-0205834-B1 | 7-THIABICYCLOHEPTANE SUBSTITUTED ETHERS | E.R. Squibb & Sons, Inc. (US) | 1990-10-31 | — | — | EP | disclosed |
| EP-0164075-B1 | 7-OXABICYCLOHEPTANE SUBSTITUTED THIO PROSTAGLANDIN ANALOGS | E.R. Squibb & Sons, Inc. (US) | 1990-09-12 | — | — | EP | disclosed |
| EP-0331496-A1 | Polyfluoride sulfonium compounds and polymerization initiator thereof | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1989-09-06 | — | — | EP | disclosed |
| US-4654364-A | ANTIINFLAMMATORY ANTIALLERGENS, ANTIPSORIATIC | E. R. SQUIBB & SONS, INC. (US) | 1987-03-31 | — | — | US | disclosed |
| US-4647585-A | Bicycloheptane substituted ethers | E. R. SQUIBB & SONS, INC. (US) | 1987-03-03 | — | — | US | disclosed |
| EP-0205834-A1 | 7-Thiabicycloheptane substituted ethers | E.R. Squibb & Sons, Inc. (US) | 1986-12-30 | — | — | EP | disclosed |
| US-4611006-A | 5,6-epoxy-7-oxabicycloheptane substituted ethers useful in the treatment of thrombotic disease | E. R. SQUIBB & SONS, INC. (US) | 1986-09-09 | — | — | US | disclosed |
| US-4595692-A | 7-thiabicycloheptane substituted ethers | E. R. SQUIBB & SONS, INC. (US) | 1986-06-17 | — | — | US | disclosed |
| US-4560698-A | ANTIINFLAMMATORY, ANALGESIC, ANTICOAGULANT, BRONCHODILATOR, VASODILATION, ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1985-12-24 | — | — | US | disclosed |
| EP-0164075-A2 | 7-Oxabicycloheptane substituted thio prostaglandin analogs | E.R. Squibb & Sons, Inc. (US) | 1985-12-11 | — | — | EP | disclosed |
| US-4258171-A | Polyphosphazene polymers containing substituted alkyl/cycloalkyl substituents | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1981-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306376-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME | CACNA1B, KCNN4, KCNN2 | MAOB 441/4885CA1 174/4885CA2 182/4885 |
| US-20060088786-A1 | Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus | ALPG, TRPC6, GNRHR | MAOB 459/4885CA1 74/4885CA2 660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.